Simply Wall St.
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year
📈
AI Sentiment
Highly Positive
8/10
Amgen Inc. News
Latest updates and market news for AMGN
13 news
Dec 9 - Dec 15, 2025
Page 1
MT Newswires
Morgan Stanley Adjusts Amgen Price Target to $304 From $329, Maintains Equalweight Rating
📊
AI Sentiment
Positive
7/10
Zacks
Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Amgen Says FDA Approves Uplizna For Autoimmune Disorder Treatment
📊
AI Sentiment
Positive
7/10
PR Newswire
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Amgen Insiders Sell US$15m Of Stock, Possibly Signalling Caution
âž–
AI Sentiment
Neutral
4/10
MT Newswires
Wells Fargo Adjusts Price Target on Amgen to $325 From $300, Maintains Equalweight Rating
📊
AI Sentiment
Positive
7/10
MT Newswires
HSBC Adjusts Price Target on Amgen to $425 From $381, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
The Wall Street Journal
Columbus’s Reputation as an Affordable City Is Making Its Homes More Expensive
âž–
AI Sentiment
Neutral
4/10
GlobeNewswire
Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb
📊
AI Sentiment
Positive
7/10
Share this news page